| Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2 S Karathedath, BM Rajamani, SM Musheer Aalam, A Abraham, ... PloS one 12 (5), e0177227, 2017 | 75 | 2017 |
| Plasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients BM Rajamani, ESB Benjamin, A Abraham, S Ganesan, KM Lakshmi, ... Scientific reports 10 (1), 20640, 2020 | 13 | 2020 |
| Prognostic plasma biomarkers of early complications and graft‐versus‐host disease in patients undergoing allogeneic hematopoietic stem cell transplantation B Balakrishnan, RSS Illangeswaran, BM Rajamani, AA Pai, IX Raj, ... EJHaem 1 (1), 219-229, 2020 | 12 | 2020 |
| Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo BM Rajamani, RSS Illangeswaran, ESB Benjamin, B Balakrishnan, ... Frontiers in Pharmacology 14, 1187066, 2023 | 4 | 2023 |
| Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines RSS Illangeswaran, DZP Jebanesan, KK Sivakumar, RT Vidhyadharan, ... Leukemia Research 128, 107054, 2023 | 4 | 2023 |
| BCR-ABL1 kinase domain mutation analysis by next generation sequencing detected additional mutations in chronic myeloid leukemia patients with suboptimal … ESB Benjamin, N Ravindra, BM Rajamani, S Anandan, B Kausalya, ... Leukemia & lymphoma 62 (6), 1528-1531, 2021 | 4 | 2021 |
| Differential Toxicity Profile of Busulfan and Treosulfan on Endothelial Cells In Vivo-Relevance to Hematopoietic Stem Cell Transplantation B Balakrishnan, RSS Illangeswaran, BM Rajamani, E Mohanan, ... Biology of Blood and Marrow Transplantation 25 (3), S190-S191, 2019 | 2 | 2019 |
| Global Gene Expression Analysis Reveals Genotoxic Effect of Nrf2 Pharmacological Inhibitor Brusatol in Myeloid Leukemia Cells-a Promising Novel Anticancer Agent RSS Illangeswaran, S Karathedath, BM Rajamani, P Balasubramanian Blood 132, 5150, 2018 | 2 | 2018 |
| Genetic Ablation of Nuclear Receptor Interacting Protein 1 (NRIP1) Sensitizes Acute Myeloid Leukemia Cells to Retinoic Acids RSS Illangeswaran, S Karathedath, A Bagchi, BM Rajamani, ... Blood 138, 1146, 2021 | 1 | 2021 |
| Molecular and Pharmacological Inhibition of ATP Binding Cassette Transporter ABCB6 Decreases Chemoresistance in Acute Myeloid Leukemia S Karathedath, RSS Illangeswaran, S Das, BM Rajamani, SK Marepally, ... Blood 130, 1254, 2017 | 1 | 2017 |
| Role of NF-E2 Related Factor 2 (NRF2) on Chemotherapy Resistance in Acute Myeloid Leukemia (AML) and the Effect of Pharmacological Inhibition of NRF2 S Karathedath, BM Rajamani, S Varatharajan, A Abraham, V Mathews, ... Blood 126 (23), 1272, 2015 | 1 | 2015 |
| Expression profiling of nuclear hormone receptors in myeloid leukemia reveals potential novel drug targets for combination therapy S Karathedath, S Ganesan, W Zhang, A Abraham, S Varatharajan, ... Blood 122 (21), 3855, 2013 | 1 | 2013 |
| Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia DZP Jebanesan, RSS Illangeswaran, BM Rajamani, RT Vidhyadharan, ... Annals of Hematology 103 (6), 1919-1929, 2024 | | 2024 |
| Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs ESB Benjamin, E Vinod, RSS Illangeswaran, BM Rajamani, ... Cellular Signalling 116, 111067, 2024 | | 2024 |
| Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation B Balakrishnan, RSS Illangeswaran, BM Rajamani, AK Arunachalam, ... Plos one 18 (10), e0293311, 2023 | | 2023 |
| Corrigendum to" Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines"[Leukemia Res … RSS Illangeswaran, DZP Jebanesan, KK Sivakumar, RT Vidhyadharan, ... Leukemia research 130, 107329, 2023 | | 2023 |
| Inhibition of BCR:: ABL1 tyrosine kinase activity Aids in the Generation of Stable Chronic Myeloid Leukemia Induced Pluripotent Stem Cells ES Bama Benjamin, D Babu, G Joshi, BM Rajamani, K Nandy, S Rani, ... bioRxiv, 2023.06. 01.543015, 2023 | | 2023 |
| Rxra Overexpression Improves the Sensitivity to Imatinib In-Vitro/in-Vivo By Disrupting the Oxidative Capacity of Chronic Myeloid Leukemia Cells RSS Illangeswaran, BM Rajamani, ESB Benjamin, S Das, ... Blood 140 (Supplement 1), 9595-9596, 2022 | | 2022 |
| Imatinib mesylate treatment improves reprogramming efficiency, and morphology of chronic myeloid leukemia derived induced pluripotent stem cells E Benjamin, G Joshi, B Rajamani, K Nandy, S Velayudhan, ... Cancer Research 82 (12_Supplement), 3153-3153, 2022 | | 2022 |
| Pharmacological inhibition of Nrf2 overcomes acquired resistance to arsenic trioxide in FLT3 mutated acute myeloid leukemia DZ Jebanesan, RS Illangeswaran, S Das, RT Vidhyadharan, ... Cancer Research 82 (12_Supplement), 3977-3977, 2022 | | 2022 |
